Antibody molecules to PD-1 and uses thereof Grant US-11827704-B2 United States of America 28 Nov 2023
Certain chemical entities, compositions and methods Grant US-11433065-B2 United States of America 06 Sep 2022
COMBINATION OF PEMBROLIZUMAB AND ERIBULIN FOR TREATING TRIPLE-NEGATIVE BREAST CANCER Grant EP-3265122-B1 European Patent Office 04 May 2022
Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one Grant US-11312718-B2 United States of America 26 Apr 2022
Method of detecting TIM-3 using antibody molecules to TIM-3 Grant US-11155620-B2 United States of America 26 Oct 2021
METHODS FOR ENRICHING EXTRACELLULAR VESICLES FROM BIOLOGICAL FLUID SAMPLES Application WO-2021211935-A1 World Intellectual Property Organisation (WIPO) 21 Oct 2021
Methods and materials for assessing and treating cancer Grant US-11060150-B2 United States of America 13 Jul 2021
Antibody molecules to TIM-3 and uses thereof Grant US-10981990-B2 United States of America 20 Apr 2021
Antibody molecules to PD-L1 and methods of treating cancer Grant US-10851165-B2 United States of America 01 Dec 2020
Antibody molecules to PD-1 and uses thereof Grant US-10752687-B2 United States of America 25 Aug 2020
Anti-PD-1 checkpoint inhibitor antibodies that block binding of PD-L1 to PD-1 Grant US-10669338-B2 United States of America 02 Jun 2020
Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one… Grant US-10550122-B2 United States of America 04 Feb 2020
Antibody molecules to TIM-3 and uses thereof Grant US-10472419-B2 United States of America 12 Nov 2019
COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER Application WO-2019099353-A1 World Intellectual Property Organisation (WIPO) 23 May 2019
Antibody molecules to PD-L1 and uses thereof Application US-9988452-B2 United States of America 05 Jun 2018
Antibody molecules to LAG-3 and uses thereof Grant US-9908936-B2 United States of America 06 Mar 2018
Antibody molecules to TIM-3 and uses thereof Grant US-9884913-B2 United States of America 06 Feb 2018
MODULATORS OF TUMOR IMMUNE RESISTANCE FOR THE TREATMENT OF CANCER Application WO-2017140803-A1 World Intellectual Property Organisation (WIPO) 24 Aug 2017
MODULATORS OF CCR9 FOR TREATING TUMOR RESISTANCE TO IMMUNE RESPONSES Application WO-2017140793-A1 World Intellectual Property Organisation (WIPO) 24 Aug 2017
Antibody molecules to TIM-3 and uses thereof Grant US-9605070-B2 United States of America 28 Mar 2017